In conclusion, ZMYND8 acted as an epigenetic regulator of NRF2 to enhance the expression of antioxidant genes and reduced iron levels in BCSCs, which protected BCSCs against ferroptosis leading to tumor initiation (Figure 10). The gene discussed is NFE2L2; the disease is neoplasm.